Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Jan-12 5:04 PM View:  | Leutzinger Kurt Chief Financial Officer | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 150,600 | $137.00 | $20,632,200.00 | (100%) 150.6K to 0 | < 1% |
| 17-Jan-12 5:11 PM View: | Hahn Elliot F Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 222,248 | $137.00 | $30,448,000.00 | (100%) 222.25K to 0 | < 1% |
| 17-Jan-12 5:14 PM View: | Conrad Herbert J Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 17,000 | $137.00 | $2,329,000.00 | (100%) 17.0K to 0 | < 1% |
| 17-Jan-12 4:58 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 14,378 | $137.00 | $1,969,790.00 | (100%) 14.38K to 0 | < 1% |
| 17-Jan-12 5:00 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 628,044 | $137.00 | $86,042,000.00 | (82%) 766.56K to 138.52K | < 1% |
| 17-Jan-12 5:13 PM View: | Inouye Michael K Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 22,000 | $137.00 | $3,014,000.00 | (100%) 22.0K to 0 | < 1% |
| 17-Jan-12 5:09 PM View: | Carney William J Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 146,330 | $137.00 | $20,047,200.00 | (100%) 146.33K to 0 | < 1% |
| 17-Jan-12 5:00 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 138,520 | $137.00 | $18,977,200.00 | (100%) 138.52K to 0 | < 1% |
| 17-Jan-12 5:04 PM View: | Leutzinger Kurt Chief Financial Officer | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 222,232 | $137.00 | $30,445,800.00 | (60%) 372.83K to 150.6K | < 1% |
| 17-Jan-12 5:11 PM View: | Hahn Elliot F Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 17,000 | $137.00 | $2,329,000.00 | (7%) 239.25K to 222.25K | < 1% |
| 17-Jan-12 5:06 PM View: | Williamson Robert F III Director | Pharmasset, Inc. (VRUS) | 12-Jan-12 | Disposition (change in control) | 7,000 | $137.00 | $959,000.00 | (100%) 7.0K to 0 | < 1% |
| 05-Dec-11 4:37 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Dec-11 | Market Option Sale | 6,252 | $130.33 | $814,823.00 | (100%) 6.25K to 0 | 1% |
| 05-Dec-11 4:37 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Dec-11 | Option Exercise | 6,252 | $8.83 | $55,205.20 | 100% 0 to 6.25K | |
| 03-Nov-11 6:30 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Nov-11 | Option Exercise | 3,124 | $6.84 | $21,352.50 | 100% 0 to 3.12K | |
| 07-Nov-11 6:16 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 01-Nov-11 | Option Exercise | 17,500 | $10.83 | $189,525.00 | 100% 0 to 17.5K | |
| 03-Nov-11 6:30 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Nov-11 | Market Option Sale | 3,124 | $74.56 | $232,925.00 | (100%) 3.12K to 0 | (3%) |
| 07-Nov-11 6:16 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 01-Nov-11 | Market Option Sale | 17,500 | $74.56 | $1,304,800.00 | (100%) 17.5K to 0 | 8% |
| 13-Oct-11 4:06 PM View: | Conrad Herbert J Director | Pharmasset, Inc. (VRUS) | 11-Oct-11 | Grant | 1,000 | -- | -- | 6% 16.0K to 17.0K | |
| 13-Oct-11 4:09 PM View: | Hahn Elliot F Director | Pharmasset, Inc. (VRUS) | 11-Oct-11 | Grant | 1,000 | -- | -- | < 1% 238.25K to 239.25K | |
| 13-Oct-11 4:09 PM View: | Inouye Michael K Director | Pharmasset, Inc. (VRUS) | 11-Oct-11 | Grant | 1,000 | -- | -- | 5% 21.0K to 22.0K | |
| 13-Oct-11 4:14 PM View: | Williamson Robert F III Director | Pharmasset, Inc. (VRUS) | 11-Oct-11 | Grant | 1,000 | -- | -- | 17% 6.0K to 7.0K | |
| 13-Oct-11 4:16 PM View: | Carney William J Director | Pharmasset, Inc. (VRUS) | 11-Oct-11 | Grant | 1,000 | -- | -- | < 1% 145.33K to 146.33K | |
| 05-Oct-11 2:23 PM View: | Price P Schaefer President & CEO Director | Pharmasset, Inc. (VRUS) | 03-Oct-11 | Option Exercise | 40,000 | $1.50 | $60,000.00 | 3% 1.57M to 1.61M | |
| 05-Oct-11 2:23 PM View: | Price P Schaefer President & CEO Director | Pharmasset, Inc. (VRUS) | 03-Oct-11 | Market Option Sale | 40,000 | $79.33 | $3,173,320.00 | (2%) 1.61M to 1.57M | 7% |
| 06-Sep-11 4:19 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Sep-11 | Market Option Sale | 3,124 | $65.63 | $205,015.00 | (100%) 3.12K to 0 | 2% |
| 06-Sep-11 4:15 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Sep-11 | Option Exercise | 40,000 | $1.50 | $60,000.00 | 5% 766.57K to 806.57K | |
| 06-Sep-11 4:19 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Sep-11 | Option Exercise | 3,124 | $10.82 | $33,817.30 | 100% 0 to 3.12K | |
| 06-Sep-11 4:15 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Sep-11 | Market Option Sale | 40,000 | $65.63 | $2,625,030.00 | (5%) 806.57K to 766.57K | 2% |
| 03-Aug-11 4:31 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Option Exercise | 8,929 | $18.60 | $166,079.00 | 124% 7.19K to 16.12K | |
| 03-Aug-11 4:33 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Market Option Sale | 937 | $119.99 | $112,431.00 | (100%) 0.94K to 0 | (5%) |
| 03-Aug-11 4:32 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Option Exercise | 20,000 | $3.00 | $60,000.00 | 5% 383.28K to 403.28K | |
| 03-Aug-11 4:33 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Option Exercise | 937 | $18.60 | $17,428.20 | 100% 0 to 0.94K | |
| 03-Aug-11 4:31 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Market Option Sale | 8,929 | $119.99 | $1,071,390.00 | (55%) 16.12K to 7.19K | (5%) |
| 03-Aug-11 4:32 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Aug-11 | Market Option Sale | 20,000 | $120.15 | $2,403,010.00 | (5%) 403.28K to 383.28K | (5%) |
| 05-Jul-11 4:33 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Jul-11 | Option Exercise | 938 | $18.60 | $17,446.80 | 100% 0 to 0.94K | |
| 05-Jul-11 4:33 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Jul-11 | Market Option Sale | 20,000 | $110.47 | $2,209,330.00 | (5%) 403.28K to 383.28K | 4% |
| 05-Jul-11 4:33 PM View: | Berrey M Michelle Chief Medical Officer | Pharmasset, Inc. (VRUS) | 01-Jul-11 | Market Option Sale | 938 | $111.83 | $104,897.00 | (100%) 0.94K to 0 | 5% |
| 05-Jul-11 4:33 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Jul-11 | Option Exercise | 20,000 | $3.00 | $60,000.00 | 5% 383.28K to 403.28K | |
| 03-Jun-11 4:31 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Jun-11 | Option Exercise | 20,000 | $3.00 | $60,000.00 | 5% 383.28K to 403.28K | |
| 03-Jun-11 4:31 PM View: | Price P Schaefer President and CEO Director | Pharmasset, Inc. (VRUS) | 01-Jun-11 | Market Option Sale | 20,000 | $100.54 | $2,010,710.00 | (5%) 403.28K to 383.28K | (< 1%) |
| 11-May-11 4:32 PM View: | Rogers Michael D. Chief Development Officer | Pharmasset, Inc. (VRUS) | 09-May-11 | Option Exercise | 10,000 | $13.88 | $138,800.00 | 100% 0 to 10.0K | |
| 11-May-11 4:32 PM View: | Rogers Michael D. Chief Development Officer | Pharmasset, Inc. (VRUS) | 09-May-11 | Market Option Sale | 10,000 | $109.08 | $1,090,800.00 | (100%) 10.0K to 0 | 2% |
| 10-May-11 4:33 PM View: | Williamson Robert F III Director | Pharmasset, Inc. (VRUS) | 06-May-11 | Market Option Sale | 20,000 | $104.36 | $2,087,160.00 | (58%) 34.67K to 14.67K | (3%) |
| 10-May-11 4:34 PM View: | Leutzinger Kurt Chief Financial Officer | Pharmasset, Inc. (VRUS) | 06-May-11 | Market Sale | 11,287 | $102.88 | $1,161,210.00 | (6%) 197.7K to 186.42K | (4%) |
| 10-May-11 4:33 PM View: | Williamson Robert F III Director | Pharmasset, Inc. (VRUS) | 06-May-11 | Market Sale | 11,666 | $104.36 | $1,217,440.00 | (80%) 14.67K to 3.0K | (3%) |
| 10-May-11 4:33 PM View: | Williamson Robert F III Director | Pharmasset, Inc. (VRUS) | 06-May-11 | Option Exercise | 20,000 | $3.00 | $60,000.00 | 136% 14.67K to 34.67K | |
| 09-May-11 4:35 PM View: | Leutzinger Kurt Chief Financial Officer | Pharmasset, Inc. (VRUS) | 05-May-11 | Market Sale | 9,546 | $102.61 | $979,515.00 | (5%) 207.25K to 197.7K | (4%) |
| 05-May-11 4:33 PM View: | Conrad Herbert J Director | Pharmasset, Inc. (VRUS) | 03-May-11 | Option Exercise | 40,000 | $17.55 | $702,000.00 | 500% 8.0K to 48.0K | |
| 05-May-11 4:33 PM View: | Conrad Herbert J Director | Pharmasset, Inc. (VRUS) | 03-May-11 | Market Option Sale | 40,000 | $99.04 | $3,961,580.00 | (83%) 48.0K to 8.0K | (8%) |
| 29-Apr-11 4:37 PM View: | Otto Michael Chief Scientific Officer | Pharmasset, Inc. (VRUS) | 28-Apr-11 | Market Sale | 9,500 | $99.85 | $948,575.00 | (57%) 16.69K to 7.19K | (7%) |
